4.6 Article

Monoallelic and biallelic &ITCREB3L1 &ITvariant causes mild and severe osteogenesis imperfecta, respectively

Journal

GENETICS IN MEDICINE
Volume 20, Issue 4, Pages 411-419

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/gim.2017.115

Keywords

bone; COPII; CREB3L1; OASIS; osteogenesis imperfecta

Funding

  1. Freudmann Research Fund at the University of Washington
  2. National Institute of Arthritis and Musculoskeletal and Skin Diseases [F31AR069971]
  3. Cell & Molecular Biology Training Grant [5T32GM007270]
  4. Molecular Medicine Training Grant [5T32GM095421]
  5. University of Washington Department of Pathology
  6. National Heart, Lung, and Blood Institute [2UM1HG006493]
  7. Collagen Diagnostic Laboratory
  8. National Human Genome Research Institute

Ask authors/readers for more resources

Purpose: Osteogenesis imperfecta (OI) is a heritable skeletal dysplasia. Dominant pathogenic variants in COLIA1 and COLIA2 explain the majority of OI cases. At least 15 additional genes have been identified, but those still do not account for all OI phenotypes that present. We sought the genetic cause of mild and lethal OI phenotypes in an unsolved family.& para;& para;Methods: We performed exome sequencing on seven members of the family, both affected and unaffected.& para;& para;Results: We identified a variant in cyclic AMP responsive element binding protein 3-like 1 (CREB3L1) in a consanguineous family. The variant caused a prenatal/perinatal lethal OI in homozygotes, similar to that seen in OI type II as a result of mutations in type I collagen genes, and a mild phenotype (fractures, blue sclerae) in multiple heterozygous family members. CREB3L1 encodes old astrocyte specifically induced substance (OASIS), an endoplasmic reticulum stress transducer. The variant disrupts a DNA-binding site and prevents OASIS from acting on its transcriptional targets including SEC24D, which encodes a component of the coat protein II complex.& para;& para;Conclusion: This report confirms that CREB3L1 is an OI-related gene and suggests the pathogenic mechanism of CREB3L1-associated OI involves the altered regulation of proteins involved in cellular secretion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pathology

Methylation Status of the Chromosome Arm 19q MicroRNA Cluster in Sporadic and Androgenetic-Biparental Mosaicism-Associated Hepatic Mesenchymal Hamartoma

Rachel B. Keller, Dina El Demellawy, Alberto Quaglia, Milton Finegold, Raj P. Kapur

PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2015)

Article Oncology

CTC1 Mutations in a patient with dyskeratosis congenita

Rachel B. Keller, Katelyn E. Gagne, G. Naheed Usmani, George K. Asdourian, David A. Williams, Inga Hofmann, Suneet Agarwal

PEDIATRIC BLOOD & CANCER (2012)

Article Oncology

Molecular Characterization and Therapeutic Targeting of Colorectal Cancers Harboring Receptor Tyrosine Kinase Fusions

Harshabad Singh, Yvonne Y. Li, Liam F. Spurr, Atul B. Shinagare, Ritika Abhyankar, Emma Reilly, Lauren K. Brais, Anwesha Nag, Matthew D. Ducar, Aaron R. Thorner, Geoffrey Shapiro, Rachel B. Keller, Cheta Siletti, Jeffrey W. Clark, Anna F. Farago, Jessica J. Lin, George D. Demetri, Rahul Gujrathi, Matthew H. Kulke, Laura E. MacConaill, Azra H. Ligon, Ewa Sicinska, Matthew L. Meyerson, Jeffrey A. Meyerhardt, Andrew D. Cherniack, Brian M. Wolpin, Kimmie Ng, Marios Giannakis, Jason L. Hornick, James M. Cleary

Summary: RTK fusions in colorectal cancer are rare but enrich in right-sided and MMR-D colorectal cancers. They occur in RAS and BRAF wild-type tumors, providing an important therapeutic target for MSS colorectal cancer.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

MatchMiner: an open-source platform for cancer precision medicine

Harry Klein, Tali Mazor, Ethan Siegel, Pavel Trukhanov, Andrea Ovalle, Catherine Del Vecchio Fitz, Zachary Zwiesler, Priti Kumari, Bernd Van Der Veen, Eric Marriott, Jason Hansel, Joyce Yu, Adem Albayrak, Susan Barry, Rachel B. Keller, Laura E. MacConaill, Neal Lindeman, Bruce E. Johnson, Barrett J. Rollins, Khanh T. Do, Brian Beardslee, Geoffrey Shapiro, Suzanne Hector-Barry, John Methot, Lynette Sholl, James Lindsay, Michael J. Hassett, Ethan Cerami

Summary: This article introduces an open-source platform called MatchMiner, which computationally matches genomically profiled cancer patients to precision medicine trials, accelerating the trial enrollment process. It provides data to demonstrate the impact of MatchMiner on trial consents.

NPJ PRECISION ONCOLOGY (2022)

Meeting Abstract Oncology

Clinical-genomic analysis of KRAS wild-type pancreatic cancer confirms alternative targetable drivers and provides insight for age and risk related clinical stratification.

Harshabad Singh, Rachel B. Keller, Kevin S. Kapner, Julien Dilly, Srivatsan Raghavan, Chen Yuan, Eizabeth Cohen, Michael Tolstorukov, Emma Hill, Elizabeth Andrews, Lauren K. Brais, Annacarolina Da Silva, Kimberly Perez, Douglas A. Rubinson, Benjamin L. Schlechter, Michael H. Rosenthal, Jason L. Hornick, Valentina Nardi, Yvonne Li, Hersh Gupta, Andrew Cherniack, Mathew L. Meyerson, James M. Cleary, Jonathan A. Nowak, Brian M. Wolpin, Andrew A. Aguirre

CANCER RESEARCH (2022)

Article Genetics & Heredity

Biallelic variants in MESD, which encodes a WNT-signaling-related protein, in four new families with recessively inherited osteogenesis imperfecta

Thao T. Tran, Rachel B. Keller, Brecht Guillemyn, Melanie Pepin, Jane E. Corteville, Samir Khatib, Mohammad-Sadegh Fallah, Sirous Zeinali, Fransiska Malfait, Sofie Symoens, Paul Coucke, Peter Witters, Elena Levtchenko, Hamideh Bagherian, Deborah A. Nickerson, Michael J. Bamshad, Jessica X. Chong, Peter H. Byers

Summary: The genetic disorder osteogenesis imperfecta is characterized by genetic heterogeneity, with most cases caused by variants in COL1A1 or COL1A2 genes. Recent studies have linked different variants in the MESD gene to the progressively deforming phenotype associated with the disorder, highlighting the crucial role of MESD in WNT signaling for bone formation.

HUMAN GENETICS AND GENOMICS ADVANCES (2021)

Meeting Abstract Oncology

MatchMiner: An open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials

Tali Mazor, Rachel B. Keller, Priti Kumai, James Lindsay, Eric Marriott, Andrea Ovalle, Ethan Siegel, Joyce Yu, Michael Hassett, Ethan Cerami

CANCER RESEARCH (2020)

Meeting Abstract Oncology

Precision oncology decision support within the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute (GI TARGET)

Rachel B. Keller, Tali Mazor, Marios Giannakis, Jonathan Nowak, Lynette Sholl, Andrew Aguirre, Adam Bass, Nilay Sethi, Ankur Nagaraja, Lauren Brais, Emma Reilly, Ethan Cerami, Brian Wolpin

MOLECULAR CANCER THERAPEUTICS (2019)

Meeting Abstract Oncology

MatchMiner: An open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials

Tali Mazor, Rachel B. Keller, Priti Kumari, James Lindsay, Eric Marriott, Andrea Ovalle, Ethan Siegel, Elizabeth H. Williams, Joyce Yu, Michael Hassett, Ethan Cerami

MOLECULAR CANCER THERAPEUTICS (2019)

Article Medicine, Research & Experimental

Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma

Graham M. Strub, Andrew L. Kirsh, Mark E. Whipple, Winston P. Kuo, Rachel B. Keller, Raj P. Kapur, Mark W. Majesky, Jonathan A. Perkins

JCI INSIGHT (2016)

Article Genetics & Heredity

Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina

Katerina S. Kucera, Beth Lincoln Boyea, Brooke Migliore, Sarah Nelson Potter, Veronica R. Robles, Oksana Kutsa, Heidi Cope, Katherine C. Okoniewski, Anne Wheeler, Catherine W. Rehder, Edward C. Smith, Holly L. Peay

Summary: Screening for elevated CK-MM levels in dried blood spots is a feasible method to identify newborns with DMD. Including specific cutoffs, repeat testing, and genetic sequencing can improve the accuracy and sensitivity of screening.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Preparing for the unexpected: Recommendations for returning secondary findings in late-stage cancer care

Madeline Currey, Ilana Solomon, Sarah Mcgraw, Jenny Shen, Francisco Munoz, Ernesto Sosa, Vanessa Puello-Lozano, Sam Wing, Lisa Lopez, Michelle Afkhami, Janine Lobello, Szabolcs Szelinger, Stacy W. Gray

Summary: This study conducted qualitative interviews with cancer patients and providers to identify gaps in clinical care and propose care delivery solutions for the return of secondary germline findings. The responses of patients varied depending on the amount of pre-test counseling they received, and providers identified insufficient clinic time as a major barrier to pretest education. Online support tools and standardized pre-test education models were favored by providers. There were differing perspectives on how pre-test education should be integrated into clinical workflows, but agreement on the inclusion of differences between somatic and germline testing, likelihood of medically actionable findings, and the possibility of being referred to a genetics provider.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Genome sequencing detects a wide range of clinically relevant copy-number variants and other genomic alterations

Kiely N. James, Shimul Chowdhury, Yan Ding, Sergey Batalov, Kelly Watkins, Yong Hyun Kwon, Lucitia Van Der Kraan, Katarzyna Ellsworth, Stephen F. Kingsmore, Lucia Guidugli

Summary: This study used genome sequencing to detect a wide range of copy-number variants (CNVs) and other non-single nucleotide variant/indel variant types. These genetic alterations accounted for 15.8% of reported variants, with deletions being the most common type. The study also found that additional genetic tests were ordered in some cases, but failed to report the variants detected by genome sequencing.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Physician services and costs after disclosure of diagnostic sequencing results in the NYCKidSeq program

Asem Berkalieva, Nicole R. Kelly, Ashley Fisher, Samuel F. Hohmann, Monisha Sebastin, Miranda Di Biase, Katherine E. Bonini, Priya Marathe, Jacqueline A. Odgis, Sabrina A. Suckiel, Michelle A. Ramos, Rosamond Rhodes, Noura S. Abul-Husn, John M. Greally, Carol R. Horowitz, Melissa P. Wasserstein, Eimear E. Kenny, Bruce D. Gelb, Bart S. Ferket

Summary: The study aims to understand the effects of returning diagnostic sequencing results on clinical actions and economic outcomes for pediatric patients with suspected genetic disorders. The results showed that patients with positive findings were more likely to receive specialist consultation, but there were no significant increases in overall physician services and costs. More large-scale studies are needed to confirm these findings.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

Incidence, prevalence, age at diagnosis, and mortality in individuals with 45,X/46,XY mosaicism: A population-based registry study

Kirstine Stochholm, Camilla Holmgard, Shanlee M. Davis, Claus H. Gravholt, Agnethe Berglund

Summary: This study assessed the incidence, prevalence, and age at diagnosis of individuals with 45,X/46,XY mosaicism and described the associated mortality pattern. The study found an increasing incidence of 45,X/46,XY mosaicism in males and a stable incidence in females. Males were diagnosed at an older age than females. Additionally, 45,X/46,XY mosaicism was associated with increased all-cause mortality.

GENETICS IN MEDICINE (2024)

Article Genetics & Heredity

DLG2 intragenic exonic deletions reinforce the link to neurodevelopmental disorders and suggest a potential association with congenital anomalies and dysmorphism

Yunjia Chen, Ender Karaca, Nathaniel H. Robin, Dana Goodloe, Ali Al-Beshri, S. Joy Dean, Anna C. E. Hurst, Andrew J. Carroll, Fady M. Mikhail

Summary: This study confirms the association between DLG2 intragenic deletions and neurodevelopmental disorders, supports the haploinsufficiency of the DLG2 gene, and suggests a potential association between these deletions and congenital anomalies and dysmorphism.

GENETICS IN MEDICINE (2024)